These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
213 related articles for article (PubMed ID: 24439052)
1. The relevance of a geriatric assessment for elderly patients with a haematological malignancy--a systematic review. Hamaker ME; Prins MC; Stauder R Leuk Res; 2014 Mar; 38(3):275-83. PubMed ID: 24439052 [TBL] [Abstract][Full Text] [Related]
2. Relevance of a Geriatric Assessment for Elderly Patients With Lung Cancer-A Systematic Review. Schulkes KJ; Hamaker ME; van den Bos F; van Elden LJ Clin Lung Cancer; 2016 Sep; 17(5):341-349.e3. PubMed ID: 27349507 [TBL] [Abstract][Full Text] [Related]
3. Geriatric assessment in older patients with a hematologic malignancy: a systematic review. Scheepers ERM; Vondeling AM; Thielen N; van der Griend R; Stauder R; Hamaker ME Haematologica; 2020 Jun; 105(6):1484-1493. PubMed ID: 32381581 [TBL] [Abstract][Full Text] [Related]
4. The G8 screening tool detects relevant geriatric impairments and predicts survival in elderly patients with a haematological malignancy. Hamaker ME; Mitrovic M; Stauder R Ann Hematol; 2014 Jun; 93(6):1031-40. PubMed ID: 24488257 [TBL] [Abstract][Full Text] [Related]
5. The Relevance of Geriatric Impairments in Patients Starting Dialysis: A Systematic Review. van Loon IN; Wouters TR; Boereboom FTJ; Bots ML; Verhaar MC; Hamaker ME Clin J Am Soc Nephrol; 2016 Jul; 11(7):1245-1259. PubMed ID: 27117581 [TBL] [Abstract][Full Text] [Related]
6. Clinical judgement and geriatric assessment for predicting prognosis and chemotherapy completion in older patients with a hematological malignancy. Hamaker ME; Augschoell J; Stauder R Leuk Lymphoma; 2016 Nov; 57(11):2560-7. PubMed ID: 27050121 [TBL] [Abstract][Full Text] [Related]
7. Identification of clinical parameters predictive of one-year survival using two geriatric tools in clinically fit older patients with hematological malignancies: Major impact of cognition. Dubruille S; Libert Y; Roos M; Vandenbossche S; Collard A; Meuleman N; Maerevoet M; Etienne AM; Reynaert C; Razavi D; Bron D J Geriatr Oncol; 2015 Sep; 6(5):362-9. PubMed ID: 26277114 [TBL] [Abstract][Full Text] [Related]
8. The value of geriatric assessments in predicting treatment tolerance and all-cause mortality in older patients with cancer. Hamaker ME; Vos AG; Smorenburg CH; de Rooij SE; van Munster BC Oncologist; 2012; 17(11):1439-49. PubMed ID: 22941970 [TBL] [Abstract][Full Text] [Related]
9. Baseline comprehensive geriatric assessment is associated with toxicity and survival in elderly metastatic breast cancer patients receiving single-agent chemotherapy: results from the OMEGA study of the Dutch breast cancer trialists' group. Hamaker ME; Seynaeve C; Wymenga AN; van Tinteren H; Nortier JW; Maartense E; de Graaf H; de Jongh FE; Braun JJ; Los M; Schrama JG; van Leeuwen-Stok AE; de Groot SM; Smorenburg CH Breast; 2014 Feb; 23(1):81-7. PubMed ID: 24314824 [TBL] [Abstract][Full Text] [Related]
10. Geriatric Assessment and Functional Decline in Older Patients with Lung Cancer. Decoster L; Kenis C; Schallier D; Vansteenkiste J; Nackaerts K; Vanacker L; Vandewalle N; Flamaing J; Lobelle JP; Milisen K; De Grève J; Wildiers H Lung; 2017 Oct; 195(5):619-626. PubMed ID: 28634893 [TBL] [Abstract][Full Text] [Related]
11. [Cancer treatment in elderly patients: evidence and clinical research]. Repetto L; Luciani A Recenti Prog Med; 2015 Jan; 106(1):23-7. PubMed ID: 25621776 [TBL] [Abstract][Full Text] [Related]
12. The effect of geriatric intervention in frail elderly patients receiving chemotherapy for colorectal cancer: a randomized trial (GERICO). Lund CM; Vistisen KK; Dehlendorff C; Rønholt F; Johansen JS; Nielsen DL BMC Cancer; 2017 Jun; 17(1):448. PubMed ID: 28659138 [TBL] [Abstract][Full Text] [Related]
13. Geriatric Assessment in Elderly Patients with End-Stage Kidney Disease. Goto NA; van Loon IN; Morpey MI; Verhaar MC; Willems HC; Emmelot-Vonk MH; Bots ML; Boereboom FTJ; Hamaker ME Nephron; 2019; 141(1):41-48. PubMed ID: 30384369 [TBL] [Abstract][Full Text] [Related]
14. Geriatric factors predict chemotherapy feasibility: ancillary results of FFCD 2001-02 phase III study in first-line chemotherapy for metastatic colorectal cancer in elderly patients. Aparicio T; Jouve JL; Teillet L; Gargot D; Subtil F; Le Brun-Ly V; Cretin J; Locher C; Bouché O; Breysacher G; Charneau J; Seitz JF; Gasmi M; Stefani L; Ramdani M; Lecomte T; Mitry E J Clin Oncol; 2013 Apr; 31(11):1464-70. PubMed ID: 23460711 [TBL] [Abstract][Full Text] [Related]
15. Fatigue at baseline is associated with geriatric impairments and represents an adverse prognostic factor in older patients with a hematological malignancy. Hofer F; Koinig KA; Nagl L; Borjan B; Stauder R Ann Hematol; 2018 Nov; 97(11):2235-2243. PubMed ID: 30054708 [TBL] [Abstract][Full Text] [Related]
16. Geriatric Assessment and Tools for Predicting Treatment Toxicity in Older Adults With Cancer. Li D; Soto-Perez-de-Celis E; Hurria A Cancer J; 2017; 23(4):206-210. PubMed ID: 28731942 [TBL] [Abstract][Full Text] [Related]
17. Prediction of treatment-related toxicity and outcome with geriatric assessment in elderly patients with solid malignancies treated with chemotherapy: a systematic review. Versteeg KS; Konings IR; Lagaay AM; van de Loosdrecht AA; Verheul HMW Ann Oncol; 2014 Oct; 25(10):1914-1918. PubMed ID: 24569912 [TBL] [Abstract][Full Text] [Related]
18. Predictive value of each geriatric assessment domain for older patients with cancer: A systematic review. Bruijnen CP; van Harten-Krouwel DG; Koldenhof JJ; Emmelot-Vonk MH; Witteveen PO J Geriatr Oncol; 2019 Nov; 10(6):859-873. PubMed ID: 30926250 [TBL] [Abstract][Full Text] [Related]
19. Geriatric Assessment in Older Adults with Multiple Myeloma. Wildes TM; Tuchman SA; Klepin HD; Mikhael J; Trinkaus K; Stockerl-Goldstein K; Vij R; Colditz G J Am Geriatr Soc; 2019 May; 67(5):987-991. PubMed ID: 30548581 [TBL] [Abstract][Full Text] [Related]
20. Predictive value of geriatric assessment for patients older than 70 years, treated with chemotherapy. Aaldriks AA; Maartense E; le Cessie S; Giltay EJ; Verlaan HA; van der Geest LG; Kloosterman-Boele WM; Peters-Dijkshoorn MT; Blansjaar BA; van Schaick HW; Nortier JW Crit Rev Oncol Hematol; 2011 Aug; 79(2):205-12. PubMed ID: 20709565 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]